The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
GSK-3 is essential in the pathogenesis of Alzheimer's disease
Abstract
Glycogen synthase kinase-3 (GSK-3) is a pivotal molecule in the development of Alzheimer's disease (AD). GSK-3beta is involved in the formation of paired helical filament (PHF)-tau, which is an integral component of the neurofibrillary tangle (NFT) deposits that disrupt neuronal function, and a marker of neurodegeneration in AD. GSK-3beta has exactly the same oligonucleotide sequence as tau-protein kinase I (TPKI), which was first purified from the microtubule fraction of bovine brain. Initially, we discovered that GSK-3beta was involved in amyloid-beta (Abeta)-induced neuronal death in rat hippocampal cultures. In the present review, we discuss our initial in vitro results and additional investigations showing that Abeta activates GSK-3beta through impairment of phosphatidylinositol-3 (PI3)/Akt signaling; that Abeta-activated GSK-3beta induces hyperphosphorylation of tau, NFT formation, neuronal death, and synaptic loss (all found in the AD brain); that GSK-3beta can induce memory deficits in vivo; and that inhibition of GSK-3alpha (an isoform of GSK-3beta) reduces Abeta production. These combined results strongly suggest that GSK-3 activation is a critical step in brain aging and the cascade of detrimental events in AD, preceding both the NFT and neuronal death pathways. Therefore, therapeutics targeted to inhibiting GSK-3 may be beneficial in the treatment of this devastating disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130
IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice
Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Géloën, A., Even, P. C., Cervera, P., & Le Bouc, Y. (2003) · Nature · doi:10.1038/nature01298 · Cited by 2,109
Morimoto, R. I. (1998) · Genes & Development · doi:10.1101/gad.12.24.3788 · Cited by 1,906
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526 · cited 1×
“Injections of Aβ42 into P301L mutant tau transgenic mice induce NFTs in the amygdala [25], therefore, in FTDP17 mutant tau mice, which already show age-related NFT formation, Aβ should accelerate brain aging by increasing the rate of NFT formation.”
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489
CREB: a Ca 2+ -Regulated Transcription Factor Phosphorylated by Calmodulin-Dependent Kinases
Sheng, M., Thompson, M. A., & Greenberg, M. E. (1991) · Science · doi:10.1126/science.1646483 · Cited by 1,488
Silva, A. J., Kogan, J. H., Frankland, P. W., & Kida, S. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.127 · Cited by 1,462
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,423
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene
Montminy, M. R., & Bilezikjian, L. M. (1987) · Nature · doi:10.1038/328175a0 · Cited by 1,357
Coupling of the RAS-MAPK Pathway to Gene Activation by RSK2, a Growth Factor-Regulated CREB Kinase
Xing, J., Ginty, D. D., & Greenberg, M. E. (1996) · Science · doi:10.1126/science.273.5277.959 · Cited by 1,248
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C. A., Lee, V. M.-Y., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,196
Heat Shock Protein 70 kDa Molecular Biology, Biochemistry, and Physiology
Kiang, J. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00028-x · Cited by 1,164
Tau is essential to β-amyloid-induced neurotoxicity
Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092136199 · Cited by 807
Mediation by a CREB Family Transcription Factor of NGF-Dependent Survival of Sympathetic Neurons
Riccio, A., Ahn, S., Davenport, C. M., Blendy, J. A., & Ginty, D. D. (1999) · Science · doi:10.1126/science.286.5448.2358 · Cited by 802
Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J.-P., & Anderton, B. H. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90774-2 · Cited by 737
Ginty, D. D., Bonni, A., & Greenberg, M. E. (1994) · Cell · doi:10.1016/0092-8674(94)90055-8 · Cited by 733
Frame, S., Cohen, P., & Biondi, R. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00253-2 · Cited by 701
Deisseroth, K., Bito, H., & Tsien, R. W. (1996) · Neuron · doi:10.1016/s0896-6273(00)80026-4 · Cited by 698
Tau protein pathology in neurodegenerative diseases
Spillantini, M. G., & Goedert, M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01337-x · Cited by 683
SELKOE, D. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05554.x · Cited by 630
Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tau
Mandelkow, E.-M., Drewes, G., Biernat, J., Gustke, N., Van Lint, J., Vandenheede, J. R., & Mandelkow, E. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81496-9 · Cited by 515
Guzowski, J. F., & McGaugh, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2693 · Cited by 478
BILLINGSLEY, M. L., & KINCAID, R. L. (1997) · Biochemical Journal · doi:10.1042/bj3230577 · Cited by 453
Nonaka, S., Hough, C. J., & Chuang, D.-M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2642 · Cited by 427
Diagnostic Criteria for Neuropathologic Assessment of Alzheimer’s Disease
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00062-6 · Cited by 410
Wilson, B. E., Mochon, E., & Boxer, L. M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5546 · Cited by 410
Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau
Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Mercken, M., Yamaguchi, H., Sugihara, S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9637 · Cited by 409
Self-citationIshiguro, K., Shiratsuchi, A., Sato, S., Omori, A., Arioka, M., Kobayashi, S., Uchida, T., & Imahori, K. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81066-9 · Cited by 402
Morfini, G., Szebenyi, G., Elluru, R., Ratner, N., & Brady, S. T. (2002) · The EMBO Journal · doi:10.1093/emboj/21.3.281 · Cited by 401
Chu, B., Soncin, F., Price, B. D., Stevenson, M. A., & Calderwood, S. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30847 · Cited by 382
Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.
Takashima, A., Noguchi, K., Sato, K., Hoshino, T., & Imahori, K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7789 · Cited by 381
Self-citationHernández, F., Borrell, J., Guaza, C., Avila, J., & Lucas, J. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01269.x · Cited by 372
Reynolds, C. H., Betts, J. C., Blackstock, W. P., Nebreda, A. R., & Anderton, B. H. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741587.x · Cited by 362
Kaang, B.-K., Kandel, E. R., & Grant, S. G. N. (1993) · Neuron · doi:10.1016/0896-6273(93)90331-k · Cited by 352
Kline, M. P., & Morimoto, R. I. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2107 · Cited by 315
Illenberger, S., Zheng-Fischhöfer, Q., Preuss, U., Stamer, K., Baumann, K., Trinczek, B., Biernat, J., Godemann, R., Mandelkow, E.-M., & Mandelkow, E. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.6.1495 · Cited by 304
Alzheimer's Presenilin 1 Mutations Impair Kinesin-Based Axonal Transport
Pigino, G., Morfini, G., Pelsman, A., Mattson, M. P., Brady, S. T., & Busciglio, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04499.2003 · Cited by 302
Glycogen Synthase Kinase-3β Facilitates Staurosporine- and Heat Shock-induced Apoptosis
Bijur, G. N., De Sarno, P., & Jope, R. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7583 · Cited by 301
The CREB family of transcription activators
Brindle, P. K., & Montminy, M. R. (1992) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80274-6 · Cited by 293
Harwood, A. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00412-3 · Cited by 291
Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
Imahori, K., & Uchida, T. (1997) · PubMed · Cited by 288
(1997) · Neuroscience · doi:10.1016/s0306-4522(96)00577-5 · Cited by 278
Fiol, C. J., Williams, J. S., Chou, C. H., Wang, Q. M., Roach, P. J., & Andrisani, O. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31619-3 · Cited by 277
Hoshi, M., Takashima, A., Noguchi, K., Murayama, M., Sato, M., Kondo, S., Saitoh, Y., Ishiguro, K., Hoshino, T., & Imahori, K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2719 · Cited by 275
Self-citationTatebayashi, Y., Miyasaka, T., Chui, D.-H., Akagi, T., Mishima, K.-I., Iwasaki, K., Fujiwara, M., Tanemura, K., Murayama, M., Ishiguro, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202205599 · Cited by 272
Self-citationLithium protects cultured neurons against β‐amyloid‐induced neurodegeneration
Alvarez, G., Muñoz-Montaño, J. R., Satrústegui, J., Avila, J., Bogónez, E., & Dı́az-Nido, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00685-7 · Cited by 270
GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila
Mudher, A., Shepherd, D., Newman, T. A., Mildren, P., Jukes, J. P., Squire, A., Mears, A., Berg, S., MacKay, D., Asuni, A. A., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001483 · Cited by 265
Takashima, A., Noguchi, K., Michel, G., Mercken, M., Hoshi, M., Ishiguro, K., & Imahori, K. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12257-5 · Cited by 260 · cited 2×
“We found that PI3 kinase is downregulated by A β , and this downregulation subsequently activates GSK-3 β [79].”
Self-citationIshiguro, K., Takamatsu, M., Tomizawa, K., Omori, A., Takahashi, M., Arioka, M., Uchida, T., & Imahori, K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50102-8 · Cited by 247
Developmental expression and localization of glycogen synthase kinase-3β in rat brain
Leroy, K., & Brion, J.-P. (1999) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(99)00012-5 · Cited by 238
Davis, G. W., Schuster, C. M., & Goodman, C. S. (1996) · Neuron · doi:10.1016/s0896-6273(00)80199-3 · Cited by 230
Targeting of the CREB gene leads to up-regulation of a novel CREB mRNA isoform.
Blendy, J. A., Kaestner, K. H., Schmid, W., Gass, P., & Schutz, G. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00447.x · Cited by 223
A novel presenilin 1 mutation associated with Pick's disease but not β‐amyloid plaques
Dermaut, B., Kumar‐Singh, S., Engelborghs, S., Theuns, J., Rademakers, R., Saerens, J., Pickut, B. A., Peeters, K., Van Den Broeck, M., Vennekens, K., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20083 · Cited by 212
The Role of APP Processing and Trafficking Pathways in the Formation of Amyloid β‐Proteina
SELKOE, D. J., YAMAZAKI, T., CITRON, M., PODLISNY, M. B., KOO, E. H., TEPLOW, D. B., & HAASS, C. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34401.x · Cited by 205
Lovestone, S., Hartley, C. L., Pearce, J., & Anderton, B. H. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00126-1 · Cited by 201
Pugazhenthi, S., Miller, E., Sable, C., Young, P., Heidenreich, K. A., Boxer, L. M., & Reusch, J. E.-B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27529 · Cited by 199
Tau gene mutations: dissecting the pathogenesis of FTDP-17
Ingram, E. M., & Spillantini, M. G. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02440-1 · Cited by 177
Insulin/IGF signalling and ageing: seeing the bigger picture
Gems, D. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00192-1 · Cited by 175
He, B., Meng, Y., & Mivechi, N. F. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6624 · Cited by 172
Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer’s disease
Goedert, M., & Spillantini, M. G. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00037-5 · Cited by 168
Bullock, B. P., & Habener, J. F. (1998) · Biochemistry · doi:10.1021/bi970982t · Cited by 167
Tau Protein in Normal and Alzheimer's Disease Brain: An Update
Johnson, G. V. W., & Hartigan, J. A. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-14-512 · Cited by 154
Formation of Filamentous Tau Aggregations in Transgenic Mice Expressing V337M Human Tau
Tanemura, K., Akagi, T., Murayama, M., Kikuchi, N., Murayama, O., Hashikawa, T., Yoshiike, Y., Park, J., Matsuda, K., Nakao, S., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0439 · Cited by 146
Self-citationSato, S., Tatebayashi, Y., Akagi, T., Chui, D.-H., Murayama, M., Miyasaka, T., Planel, E., Tanemura, K., Sun, X., Hashikawa, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202241200 · Cited by 146
Self-citationTakahashi, M., Tomizawa, K., Kato, R., Sato, K., Uchida, T., Fujita, S., & Imahori, K. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63010245.x · Cited by 129
Godemann, R., Biernat, J., Mandelkow, E., & Mandelkow�, E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00741-3 · Cited by 122
D’Mello, S. R., Anelli, R., & Calissano, P. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1095 · Cited by 119
Molecular Genetics of Chromosome 17 Tauopathies
HUTTON, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06906.x · Cited by 92 · cited 2×
“The FTDP-17 tau mouse fits this requirement, because these mice (expressing FTDP-17 mutant human tau) exhibit NFTs without Aβ deposition [23,35,36,39,74,85].”
Michel, G., Mercken, M., Murayama, M., Noguchi, K., Ishiguro, K., Imahori, K., & Takashima, A. (1998) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(97)00139-6 · Cited by 92
Self-citationAnalysis of phosphorylation of tau with antibodies specific for phosphorylation sites
Ishiguro, K., Sato, K., Takamatsu, M., Park, J., Uchida, T., & Imahori, K. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12206-0 · Cited by 90
Kim, J. W., Lee, J. E., Kim, M., Cho, E., Cho, S., & Choi, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300253200 · Cited by 85
Tau Protein in Normal and Alzheimer's Disease Brain
Johnson, G. V., & Jenkins, S. (1999) · Journal of Alzheimer's Disease · doi:10.3233/jad-1999-14-511 · Cited by 83
Yang, S., Song, J., Yu, J., & Shiah, S. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09811.x · Cited by 80
A Novel Tubulin-Dependent Protein Kinase Forming a Paired Helical Filament Epitope on Tau
Ishiguro, K., Ihara, Y., Uchida, T., & Imahori, K. (1988) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a122465 · Cited by 80
Familial Frontotemporal Dementia Associated with a Novel Presenilin-1 Mutation
Tang‐Wai, D. F., Lewis, P. A., Boeve, B. F., Hutton, M. L., Golde, T. E., Baker, M., Hardy, J., Michels, V. V., Ivnik, R. J., Jack, C. R., et al. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000058328 · Cited by 73
CREB Proteins Function as Positive Regulators of the Translocated -2 Allele in t(14;18) Lymphomas
Ji, L., Mochon, E., Arcinas, M., & Boxer, L. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22687 · Cited by 68
Molecular Cloning and Characterization of the Human Glycogen Synthase Kinase-3β Promoter
Lau, K., Miller, C. C. J., Anderton, B. H., & Shaw, P. (1999) · Genomics · doi:10.1006/geno.1999.5875 · Cited by 68
Alberts, A. S., Arias, J., Hagiwara, M., Montminy, M., & Feramisco, J. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37333-7 · Cited by 66
Takashima, A., Yamaguchi, H., Noguchi, K., Michel, G., Ishiguro, K., Sato, K., Hoshino, T., Hoshi, M. M., & Imahori, K. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11964-x · Cited by 54
Self-citationTakahashi, M., Tomizawa, K., & Ishiguro, K. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02424-5 · Cited by 49
Bijur, G. N., Davis, R. E., & Jope, R. S. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00168-0 · Cited by 36
Nuclear Glycogen and Glycogen Synthase Kinase 3
Ragano‐Caracciolo, M., Berlin, W. K., Miller, M. W., & Hanover, J. A. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9159 · Cited by 29
Phenotypic Variation in Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17
Swieten, J. C. V., Rosso, S. M., van Herpen, E., Kamphorst, W., Ravid, R., & Heutink, P. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000077150 · Cited by 27
Alternative transcripts of presenilin-1 associated with frontotemporal dementia
Evin, G. M., Smith, M. J., Tziotis, A., McLean, C., Canterford, L. D., Sharples, R. A., Cappai, R., Weidemann, A., Beyreuther, K. T., Cotton, R. G. H., et al. (2002) · Neuroreport · doi:10.1097/00001756-200204160-00036 · Cited by 22
Cited by
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Gong, C.-X., & Iqbal, K. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785909111 · Cited by 644
Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes
Liu, Y., Liu, F., Grundke‐Iqbal, I., Iqbal, K., & Gong, C. (2011) · The Journal of Pathology · doi:10.1002/path.2912 · Cited by 502
TFEB and TFE3: Linking Lysosomes to Cellular Adaptation to Stress
Raben, N., & Puertollano, R. (2016) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125407 · Cited by 437
Microtubule-associated protein tau in development, degeneration and protection of neurons
Wang, J.-Z., & Liu, F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.002 · Cited by 398
Metadata
- Authors
- Takashima, A.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2006-07-27
- Volume
- 9
- Issue
- s3
- Pages
- 309-317
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W328531019
- Cited by
- 396
- References
- 86
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.